Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

US Patent 6900194 · Granted May 31, 2005

Estimated economic value: $539,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inducible modification of a cell genome2025
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Modified UBE3A gene for a gene therapy approach for angelman syndrome2022
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
Branched 3-phenylpropionic acid derivatives and their use2022
Gene modification assays2022
Inducible modification of a cell genome2021
Recombinant adeno-associated virus-mediated expression of fractalkine for treatm2020
Substituted 5-fluoro-1H-pyrazolopyridines and their use2020
(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use2020
Factor XI antibodies and methods of use2019
Arginine deiminase gene therapy for disordered proteins2019